Balfe J W, Qamar I
Division of Nephrology, Hospital for Sick Children, University of Toronto, Ontario, Canada.
Perit Dial Int. 1993;13 Suppl 2:S95-7.
Changes in the formulation of peritoneal dialysis solutions will continue. For the present, dextrose dialysis will remain the osmotic solute of choice. How amino acids and glucose polymers as solute replacements for glucose fit into the dialysis prescription remains to be seen. The lower concentration of calcium and magnesium appears to be gaining acceptance in many centers. It is feasible that in the next few years the challenge of adding bicarbonate to the peritoneal dialysis solution will be circumvented, because there appears to be a real clinical need for such an improvement. Pediatric modifications will be necessary, appreciating that such changes will have an economic penalty, and thus must have proven value.
腹膜透析液配方的改变仍将持续。目前,葡萄糖透析液仍是首选的渗透溶质。氨基酸和葡萄糖聚合物作为葡萄糖溶质替代品如何融入透析处方还有待观察。钙和镁浓度较低的透析液在许多中心似乎越来越被接受。在未来几年内,规避向腹膜透析液中添加碳酸氢盐的挑战是可行的,因为临床上对此类改进似乎有切实需求。必须进行儿科方面的调整,同时要认识到此类改变会带来经济成本,因此必须具有已证实的价值。